BRPI0820177A2 - Métodos para produzir um extrato de proteína a partir de células fixadas ou não-fixadas e para detectar uma proteína alvo, sistema para produzir um extrato de proteína, kit para produzir um extrato de proteína de células fixadas ou não-fixadas, e, método para extrair uma proteína viral alvo de uma amostra celular - Google Patents

Métodos para produzir um extrato de proteína a partir de células fixadas ou não-fixadas e para detectar uma proteína alvo, sistema para produzir um extrato de proteína, kit para produzir um extrato de proteína de células fixadas ou não-fixadas, e, método para extrair uma proteína viral alvo de uma amostra celular

Info

Publication number
BRPI0820177A2
BRPI0820177A2 BRPI0820177-3A2A BRPI0820177A BRPI0820177A2 BR PI0820177 A2 BRPI0820177 A2 BR PI0820177A2 BR PI0820177 A BRPI0820177 A BR PI0820177A BR PI0820177 A2 BRPI0820177 A2 BR PI0820177A2
Authority
BR
Brazil
Prior art keywords
protein
extract
produce
target
detect
Prior art date
Application number
BRPI0820177-3A2A
Other languages
English (en)
Inventor
Adrien P Malick
Virginia M Crews
Julie L Rosales
Carrie S Ferguson
Jefferey H Bruton
Robert J Beadenkopf
John Mantlo
Original Assignee
Becton Dickinson Co
Arbor Vita Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co, Arbor Vita Corp filed Critical Becton Dickinson Co
Publication of BRPI0820177A2 publication Critical patent/BRPI0820177A2/pt
Publication of BRPI0820177B1 publication Critical patent/BRPI0820177B1/pt
Publication of BRPI0820177B8 publication Critical patent/BRPI0820177B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4044—Concentrating samples by chemical techniques; Digestion; Chemical decomposition
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
BRPI0820177A 2007-11-14 2008-11-14 métodos para produzir um extrato de proteína a partir de células fixadas ou não-fixadas BRPI0820177B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/985,547 US9207240B2 (en) 2007-11-14 2007-11-14 Method of efficient extraction of protein from cells
US11/985547 2007-11-14
PCT/US2008/083707 WO2009065091A1 (en) 2007-11-14 2008-11-14 Method of efficient extraction of protein from cells

Publications (3)

Publication Number Publication Date
BRPI0820177A2 true BRPI0820177A2 (pt) 2014-11-04
BRPI0820177B1 BRPI0820177B1 (pt) 2019-07-02
BRPI0820177B8 BRPI0820177B8 (pt) 2021-07-27

Family

ID=40624059

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0820177A BRPI0820177B8 (pt) 2007-11-14 2008-11-14 métodos para produzir um extrato de proteína a partir de células fixadas ou não-fixadas

Country Status (9)

Country Link
US (2) US9207240B2 (pt)
EP (1) EP2222838B1 (pt)
JP (1) JP5787519B2 (pt)
CN (2) CN101910400B (pt)
AU (1) AU2008322473B2 (pt)
BR (1) BRPI0820177B8 (pt)
CA (1) CA2705765C (pt)
ES (1) ES2456341T3 (pt)
WO (1) WO2009065091A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2024520B1 (en) * 2006-05-11 2014-03-05 Becton, Dickinson and Company Method of protein extraction from cells
US8859218B2 (en) * 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
US9207240B2 (en) 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells
BR112012004699B1 (pt) * 2009-09-03 2019-10-15 Becton, Dickinson And Company Métodos, composições e kits para lise química direta
US8658417B2 (en) * 2009-09-15 2014-02-25 Qiagen Gaithersburg, Inc. Multiple-input analytical system
US8994937B2 (en) 2012-04-18 2015-03-31 Hewlett-Packard Development Company, L.P. Surface enhanced Raman spectroscopy calibration curve generating systems
US9680916B2 (en) 2013-08-01 2017-06-13 Flowtraq, Inc. Methods and systems for distribution and retrieval of network traffic records
JP6397224B2 (ja) * 2014-06-04 2018-09-26 田中貴金属工業株式会社 免疫学的測定試薬におけるプロゾーン現象の解消法
CN104237198A (zh) * 2014-07-31 2014-12-24 中国人民解放军第二军医大学 一种判定中药材或中药饮片是否染色的方法
CN109154616B (zh) * 2016-05-31 2022-07-12 豪夫迈·罗氏有限公司 用于病毒抗原的血清学检测的方法
CN107621462B (zh) * 2016-07-13 2020-03-31 王志伟 一种组织透明化液sut及其制备和应用
CN113832116B (zh) * 2017-01-12 2024-09-13 厦门大学 稳定呼吸道合胞病毒融合蛋白的方法
AU2018391478B9 (en) * 2017-12-22 2024-10-10 Basf Plant Science Company Gmbh Method and means for an isolation of membrane-bound proteins from a biological sample, preferably processed plant seed meal
JP7267548B2 (ja) * 2019-04-24 2023-05-02 株式会社ニップン トマト黄化葉巻ウイルス（ｔｙｌｃｖ）の免疫学的診断法
CN112213164A (zh) * 2019-07-12 2021-01-12 温州医科大学附属第一医院 一种总蛋白提取试剂盒及提取方法
CN116223793A (zh) * 2023-02-14 2023-06-06 上海乐备实生物技术有限公司 一种用于外泌体中补体检测的裂解液及其应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546334A (en) * 1965-05-21 1970-12-08 Lerner Lab Inc Composition for fixing and protecting a smear of body cells and method of applying same
US3303038A (en) * 1965-07-29 1967-02-07 Ethicon Inc Process of forming collagen articles and dispersions
JPS5535088B2 (pt) * 1971-09-10 1980-09-11
US4578282A (en) * 1982-02-04 1986-03-25 Harrison James S Composition for diagnostic reagents
US4766065A (en) 1984-08-23 1988-08-23 Becton Dickinson And Company Detection of cell membrane protein
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
US4857300A (en) * 1987-07-27 1989-08-15 Cytocorp, Inc. Cytological and histological fixative formulation and methods for using same
US5047325A (en) 1988-10-07 1991-09-10 Eastman Kodak Company Wash solution containing a cationic surfactant and its use in chlamydial and gonococcal determinations
US5132205A (en) 1988-10-07 1992-07-21 Eastman Kodak Company High ph extraction composition and its use to determine a chlamydial, gonococcal or herpes antigen
US5081010A (en) 1989-02-09 1992-01-14 Eastman Kodak Company Extraction composition, test kit and their use to extract or determine herpes simplex viral antigen
US5104640A (en) * 1989-03-17 1992-04-14 Wescor, Inc. Fixative composition for fixing blood smears to slides
US5256571A (en) * 1991-05-01 1993-10-26 Cytyc Corporation Cell preservative solution
US5196182A (en) * 1991-05-08 1993-03-23 Streck Laboratories, Inc. Tissue fixative
US5773277A (en) * 1992-06-26 1998-06-30 Seikagaku Kogyo Kabushiki Kaisha Crystalline chondroitinase isolated from Proteus vulgaris ATCC 6896
US5432056A (en) * 1993-11-15 1995-07-11 Ventana Medical Systems, Inc. Bisulfite-based tissue fixative
US5658749A (en) * 1994-04-05 1997-08-19 Corning Clinical Laboratories, Inc. Method for processing mycobacteria
US5620869A (en) * 1995-09-28 1997-04-15 Becton, Dickinson And Company Methods for reducing inhibition of nucleic acid amplification reactions
US7306926B2 (en) * 1998-07-01 2007-12-11 Mtm Laboratories Ag Method for detecting carcinomas in a solubilized cervical body sample
US6245568B1 (en) 1999-03-26 2001-06-12 Merck & Co., Inc. Human papilloma virus vaccine with disassembled and reassembled virus-like particles
US20050019841A1 (en) * 1999-05-14 2005-01-27 Arbor Vita Corporation Modulation of signaling pathways
US20050037969A1 (en) * 1999-05-14 2005-02-17 Arbor Vita Corporation Molecular interactions in hematopoietic cells
US20060148711A1 (en) * 1999-05-14 2006-07-06 Arbor Vita Corporation Molecular interactions in neurons
US6488671B1 (en) * 1999-10-22 2002-12-03 Corazon Technologies, Inc. Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
UA76708C2 (uk) * 1999-12-08 2006-09-15 Сінгента Патисипейшонс Аг Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду
US6337189B1 (en) * 2000-02-08 2002-01-08 Streck Laboratories, Inc. Fixative system, method and composition for biological testing
US6436662B1 (en) * 2000-04-04 2002-08-20 Digene Corporation Device and method for cytology slide preparation
WO2002007751A1 (en) * 2000-07-25 2002-01-31 Axcell Biosciences Corporation Identification and isolation of novel polypeptides having pdz domains and methods of using same
EP1325300A1 (en) * 2000-09-15 2003-07-09 Biogenex Laboratories ENHANCEMENT OF i IN SITU /i HYBRIDIZATION
US7312041B2 (en) * 2001-02-16 2007-12-25 Arbor Vita Corporation Methods of diagnosing cervical cancer
DK2267452T3 (da) 2001-06-22 2012-10-29 Hoffmann La Roche Opløseligt kompleks omfattende et retroviralt overfladeglycoprotein
US20050032105A1 (en) * 2001-10-12 2005-02-10 Bair Robert Jackson Compositions and methods for using a solid support to purify DNA
EP1507148B1 (en) 2003-08-25 2005-02-23 MTM Laboratories AG Method for detecting carcinomas in a solubilized cervical body sample
EP1537415B1 (en) 2002-09-09 2008-12-17 Arbor Vita Corporation Methods of diagnosing cervical cancer
US7319021B2 (en) * 2002-11-01 2008-01-15 Promega Corporation Cell lysis composition, methods of use, apparatus and kit
EP1694692B1 (en) * 2003-12-16 2010-04-28 QIAGEN North American Holdings, Inc. Formulations and methods for denaturing proteins
AU2004308964B2 (en) * 2003-12-23 2010-09-16 Arbor Vita Corporation Antibodies for oncogenic strains of HPV and methods of their use
EP1743032A4 (en) * 2004-04-15 2007-09-05 Allied Biotech Inc METHODS AND APPARATUS FOR DETECTING VIRAL INFECTIONS
US8163563B2 (en) * 2004-06-09 2012-04-24 Pathogen Removal And Diagnostic Technologies, Inc. Devices and methods for removing target agents from a sample
EP2024520B1 (en) 2006-05-11 2014-03-05 Becton, Dickinson and Company Method of protein extraction from cells
US9207240B2 (en) 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells

Also Published As

Publication number Publication date
US9207240B2 (en) 2015-12-08
EP2222838A1 (en) 2010-09-01
EP2222838B1 (en) 2014-01-22
CN101910400A (zh) 2010-12-08
US20160216258A1 (en) 2016-07-28
ES2456341T3 (es) 2014-04-22
EP2222838A4 (en) 2011-01-05
JP5787519B2 (ja) 2015-09-30
BRPI0820177B1 (pt) 2019-07-02
US9995745B2 (en) 2018-06-12
AU2008322473A1 (en) 2009-05-22
BRPI0820177B8 (pt) 2021-07-27
WO2009065091A1 (en) 2009-05-22
AU2008322473B2 (en) 2014-07-03
CN107629109A (zh) 2018-01-26
CN101910400B (zh) 2017-06-27
CA2705765C (en) 2018-12-11
JP2011503208A (ja) 2011-01-27
US20090123910A1 (en) 2009-05-14
CA2705765A1 (en) 2009-05-22

Similar Documents

Publication Publication Date Title
Farley et al. Identification and quantification of protein posttranslational modifications
BR112012016119A2 (pt) detecção de carga biológica viva com o uso de micropartículas
BRPI1013896A2 (pt) Célula de levedura, e, métodos para produzir um composto isoprenóide e para detectar em uma amostra biológica a presença ou ausência de uma célula microbiana geneticamente.
BRPI0911390A2 (pt) sistema de centrifugação de uso único para separação centrífuga de células em uma batelada de cultura celular
BRPI0811453A2 (pt) Sistema de análise de amostra
BRPI1009366A2 (pt) método e sistema de detecção de analito em tecido sólido in vitro
BRPI0815657A2 (pt) Sistema para coleta de amostra e rastreio de material vegetal
PT3185012T (pt) Método para identificação, seleção e análise de células tumorais
BRPI0819517A2 (pt) "método para detectar a presença de um microorganismo alvo em uma amostra"
IT1406051B1 (it) Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo.
DK2183599T3 (da) Højfølsomme immunoassays og kits til bestemmelse af peptider og proteiner af biologisk interesse
BR112012002137A2 (pt) método para um polipeptídeo e/ou vírus de interesse em uma cultura de célula contínua,e, composição
WO2007133682A3 (en) 100% sequence identity detection methods for variable genomes
BRPI1016065A2 (pt) "processo para detectar, de maneira quantitativa, uma proteína alvo em uma amostra."
BR112012031860A2 (pt) método para detecção de um alvo biológico em um ensaio de afinidade, disposição de detecção para um alvo biológico e porção de captura para uso em um método
WO2010092164A3 (en) Bacterial dna as markers of cardiovascular and/or metabolic disease
SG10201807867XA (en) Simultaneous detection of target protein and target nucleic acids in a single cell
WO2012082742A3 (en) Detecting cancer with anti-ccl25 and anti-ccr9 antibodies
BR112013000340A2 (pt) anticorpo isolado que se liga a neuropilina-1 (nrp1), ácido nucleico isolado, célula hospedeira, método de produção de um anticorpo, imunoconjugado e método de detecção da presença de nrp1 em uma amostra biológica
WO2009020596A3 (en) Embryonic cerebrospinal fluis (e-csf), proteins from e-csf, and related methods and compositions
BRPI0916111A2 (pt) cubeta para armazenar uma amostra biol[ogica a ser analisada por meio de uma técnica de detecção pré definida, método para a fabricação de uma cubeta, método para autenticar uma cubeta, método para analisar uma amostra biológica e sistema para analisar uma amostra biológica
EP2208795A4 (en) NUCLEIC ACID DETECTION METHOD AND NUCLEIC ACID DETERGENT KIT
BRPI0818721A2 (pt) Método e sistema para a detecção de um tipo selecionado de moléculas em uma amostra.
BRPI1009460A2 (pt) domínio de ligação do anticorpo, anticorpo, uso de um domínio de ligação ou anticorpo, método para detectar a presença de células cancerígenas em uma amostra.
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C07K 1/36 (2006.01), C12N 5/071 (2010.01)

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/07/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/07/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/11/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2644 DE 08-09-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.